PBE vs. WDNA
Compare and contrast key facts about Invesco Dynamic Biotechnology & Genome ETF (PBE) and WisdomTree BioRevolution Fund (WDNA).
PBE and WDNA are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. PBE is a passively managed fund by Invesco that tracks the performance of the Dynamic Biotech & Genome Intellidex Index (AMEX). It was launched on Jun 23, 2005. WDNA is a passively managed fund by WisdomTree that tracks the performance of the WisdomTree BioRevolution Index. It was launched on Jun 3, 2021. Both PBE and WDNA are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Performance
PBE vs. WDNA - Performance Comparison
Loading graphics...
PBE vs. WDNA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
PBE Invesco Dynamic Biotechnology & Genome ETF | -3.51% | 24.84% | 1.10% | 3.71% | -10.83% | 0.21% |
WDNA WisdomTree BioRevolution Fund | 2.99% | 22.68% | -14.18% | -2.07% | -26.29% | -5.27% |
Returns By Period
In the year-to-date period, PBE achieves a -3.51% return, which is significantly lower than WDNA's 2.99% return.
PBE
- 1D
- 3.03%
- 1M
- -3.31%
- YTD
- -3.51%
- 6M
- 14.03%
- 1Y
- 26.26%
- 3Y*
- 8.51%
- 5Y*
- 1.51%
- 10Y*
- 7.52%
WDNA
- 1D
- 4.08%
- 1M
- -4.89%
- YTD
- 2.99%
- 6M
- 14.31%
- 1Y
- 41.33%
- 3Y*
- 2.41%
- 5Y*
- —
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
PBE vs. WDNA - Expense Ratio Comparison
PBE has a 0.59% expense ratio, which is higher than WDNA's 0.45% expense ratio.
Return for Risk
PBE vs. WDNA — Risk / Return Rank
PBE
WDNA
PBE vs. WDNA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco Dynamic Biotechnology & Genome ETF (PBE) and WisdomTree BioRevolution Fund (WDNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PBE | WDNA | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.16 | 1.40 | -0.24 |
Sortino ratioReturn per unit of downside risk | 1.73 | 2.06 | -0.33 |
Omega ratioGain probability vs. loss probability | 1.22 | 1.25 | -0.03 |
Calmar ratioReturn relative to maximum drawdown | 2.12 | 3.20 | -1.08 |
Martin ratioReturn relative to average drawdown | 6.21 | 7.58 | -1.37 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| PBE | WDNA | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.16 | 1.40 | -0.24 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.07 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.30 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.32 | -0.24 | +0.56 |
Correlation
The correlation between PBE and WDNA is 0.86, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
PBE vs. WDNA - Dividend Comparison
PBE's dividend yield for the trailing twelve months is around 1.09%, less than WDNA's 4.43% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PBE Invesco Dynamic Biotechnology & Genome ETF | 1.09% | 1.00% | 0.05% | 0.02% | 0.00% | 0.00% | 0.04% | 0.00% | 0.00% | 0.57% | 0.38% | 1.12% |
WDNA WisdomTree BioRevolution Fund | 4.43% | 4.57% | 0.75% | 0.80% | 0.38% | 0.10% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
PBE vs. WDNA - Drawdown Comparison
The maximum PBE drawdown since its inception was -45.69%, smaller than the maximum WDNA drawdown of -58.87%. Use the drawdown chart below to compare losses from any high point for PBE and WDNA.
Loading graphics...
Drawdown Indicators
| PBE | WDNA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -45.69% | -58.87% | +13.18% |
Max Drawdown (1Y)Largest decline over 1 year | -11.73% | -11.70% | -0.03% |
Max Drawdown (5Y)Largest decline over 5 years | -34.71% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -37.84% | — | — |
Current DrawdownCurrent decline from peak | -7.54% | -33.71% | +26.17% |
Average DrawdownAverage peak-to-trough decline | -16.33% | -35.79% | +19.46% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.01% | 5.20% | -1.19% |
Volatility
PBE vs. WDNA - Volatility Comparison
The current volatility for Invesco Dynamic Biotechnology & Genome ETF (PBE) is 7.57%, while WisdomTree BioRevolution Fund (WDNA) has a volatility of 8.88%. This indicates that PBE experiences smaller price fluctuations and is considered to be less risky than WDNA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| PBE | WDNA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.57% | 8.88% | -1.31% |
Volatility (6M)Calculated over the trailing 6-month period | 13.75% | 18.59% | -4.84% |
Volatility (1Y)Calculated over the trailing 1-year period | 22.72% | 29.63% | -6.91% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.70% | 25.17% | -2.47% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 25.15% | 25.17% | -0.02% |